Dean Y. Li - 03 Apr 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
03 Apr 2023
Net transactions value
$0
Form type
4
Filing time
05 Apr 2023, 18:00:53 UTC
Previous filing
25 Jan 2023
Next filing
04 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1,724 +0.28% $0.000000 623,409 03 Apr 2023 Direct F1
holding RXRX Class A Common Stock 1,315,000 03 Apr 2023 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1,422,048 03 Apr 2023 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 450,000 03 Apr 2023 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.